Glenmark rallies above 20-DMA but nears overbought zone

Glenmark pharmaceuticals closed near ₹2,299 after a strong rebound from the recent ₹2,150–₹2,200 support zone. The stock has moved above its 20-day moving average near ₹2,259, showing that short-term momentum has improved. However, it remains below the 55-day moving average around ₹2,349, which is the key resistance for a broader recovery. The stochastic oscillator is near overbought territory, with %K around 90.6 and %D near 82.9. This confirms strong buying momentum, but it also signals that the rally may face profit-booking near resistance. The current setup is positive in the short term, yet chasing the move near ₹2,350 can be risky without a clear breakout. ₹2,350 is the crucial level to watch in

. A sustained close above it can extend the recovery toward ₹2,400–₹2,450. If the stock fails to cross ₹2,350, it may consolidate back toward ₹2,300 and the 20-day average near ₹2,259. The technical picture has improved, but the trend is not fully reversed until Glenmark moves above ₹2,350. The ideal confirmation would be a breakout above this level with the stochastic remaining strong rather than turning down sharply.